1. The use of circulating biomarkers in early clinical trials in patients with cancer. (October 2015) Authors: D'Arcangelo, Manolo; Margetts, Jane; Greystoke, Alastair Journal: Biomarkers in medicine Issue: Volume 9:Number 10(2015) Page Start: 1011 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Health-related quality of life (HRQoL) in patients (pts) with progressive, poorly differentiated, extra-pulmonary neuroendocrine carcinoma (PD-EP-NEC) enrolled in NET-02: A phase II trial of liposomal irinotecan (nal-IRI)/5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line therapy. Issue 28 (1st October 2022) Authors: Craig, Zoe; Swain, Jayne; Sharma, Rohini; Faluyi, Olusola Olusesan; Wadsley, Jonathan; Morgan, Carys; Wall, Lucy R.; Chau, Ian; Reed, Nicholas Simon; Sarker, Debashis; Margetts, Jane; Krell, Daniel; Cave, Judith; Sharmila, Sothi; Anthoney, Alan; Patel, Alkesh; Lamarca, Angela; Hubner, Richard A; ... Journal: Journal of clinical oncology Issue: Volume 40:Issue 28(2022)Supplement Page Start: 293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. COVID-19 and liver cancer: lost patients and larger tumours. Issue 1 (21st April 2022) Authors: Geh, Daniel; Watson, Robyn; Sen, Gourab; French, Jeremy J; Hammond, John; Turner, Paul; Hoare, Tim; Anderson, Kirsty; McNeil, Michael; McPherson, Stuart; Masson, Steven; Dyson, Jessica; Donnelly, Mhairi; MacDougal, Louise; Patel, Preya; Hudson, Mark; Anstee, Quentin M; White, Steven; Robinson, St... Journal: BMJ open gastroenterology Issue: Volume 9:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗